Loading...
Impact of infant pneumococcal conjugate vaccination on community acquired pneumonia hospitalization in all ages in the Netherlands.
van Deursen, A M M Schurink-Van't Klooster, T M Man, W H van de Kassteele, J van Gageldonk-Lafeber, A B Bruijning-Verhagen, P C J L de Melker, H E Sanders, E A M Knol, M J
van Deursen, A M M
Schurink-Van't Klooster, T M
Man, W H
van de Kassteele, J
van Gageldonk-Lafeber, A B
Bruijning-Verhagen, P C J L
de Melker, H E
Sanders, E A M
Knol, M J
Citations
Altmetric:
Series / Report no.
Open Access
Type
Article
Language
en
Date of publication
2017
Year of publication
Research Projects
Organizational Units
Journal Issue
Title
Impact of infant pneumococcal conjugate vaccination on community acquired pneumonia hospitalization in all ages in the Netherlands.
Translated Title
Published in
Vaccine 2017; 35(51):7107-13
Abstract
The long-term impact of pneumococcal conjugate vaccines on pneumonia hospitalizations in all age-groups varies between countries. In the Netherlands, the 7-valent pneumococcal conjugate vaccine (PCV7) was implemented for newborns in 2006 and replaced by PCV10 in 2011. We assessed the impact of PCVs on community-acquired pneumonia (CAP) hospitalization rates in all age-groups.